The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the ...
Integrating tobacco-cessation services into HIV and tuberculosis care can enhance treatment outcomes and reduce mortality. Health systems should implement comprehensive tobacco-cessation strategies, ...
Pulmonary diseases pose a major health problem worldwide with millions of affected individuals and dire economic impact.
Gauteng health authorities are making progress in starting RR-TB patients on treatment, but a new NICD report shows that many still face delays or are never traced after diagnosis.
Initial blood work found hints of an infection, and the doctors initially suspected a bacterial skin infection (cellulitis) ...
Positive results mark an important step forward in efforts to develop effective treatments for children with drug-resistant TB COPENHAGEN, Denmark, Nov. 19, 2025 /PRNewswire/ -- New interim data from ...
Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, ...
Statista on MSN
Drug-Resistant TB Slows Path to Global 90% Target
This chart shows the share of people diagnosed with tuberculosis (TB) who were cured/completed their treatment, by TB type (in %)*.
The nation cut tuberculosis mortality by over 50 per cent and incidence by 20 per cent, placing it among the world's top performers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results